The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.

[1]  B. Teh,et al.  Cholangiocarcinoma , 2021, Nature Reviews Disease Primers.

[2]  D. Schuppan,et al.  Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. , 2008, Gastroenterology.

[3]  H. Friess,et al.  Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. , 2008, Journal of hepatology.

[4]  M. Pekalski,et al.  Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease , 2008, Laboratory Investigation.

[5]  A. Gown,et al.  Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. , 2009, Archives of pathology & laboratory medicine.

[6]  P. Weinreb,et al.  Role of αvβ6 integrin in acute biliary fibrosis , 2007 .

[7]  D. Schuppan,et al.  Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. , 2007, Journal of hepatology.

[8]  P. Weinreb,et al.  Role of alphavbeta6 integrin in acute biliary fibrosis. , 2007, Hepatology.

[9]  G. Gores,et al.  Cholangiocarcinoma: modern advances in understanding a deadly old disease. , 2006, Journal of hepatology.

[10]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[11]  J. Haier,et al.  Integrins in cancer treatment. , 2006, Current cancer drug targets.

[12]  Yury Popov,et al.  Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. , 2005, Journal of hepatology.

[13]  C. Moskaluk,et al.  CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. , 2005, Human pathology.

[14]  P. Oettgen,et al.  Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. , 2005, The Journal of clinical investigation.

[15]  S. Goodman,et al.  Immunohistochemical screening for β6‐integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitro , 2004 .

[16]  D. Stolz,et al.  Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT , 2004, Transplantation.

[17]  J. Bavaria,et al.  Integrin expression in non-small cell carcinoma of the lung , 1995, Cancer and Metastasis Reviews.

[18]  H. Larjava,et al.  Increased expression of beta6-integrin in skin leads to spontaneous development of chronic wounds. , 2004, The American journal of pathology.

[19]  S. Goodman,et al.  Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. , 2004, Histopathology.

[20]  M. Makuuchi,et al.  Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. , 2003, Japanese journal of clinical oncology.

[21]  T. Minamoto,et al.  Expression of αv Integrin Family in Gastric Carcinomas: Increased αvβ6 is Associated with Lymph Node Metastasis , 2003 .

[22]  T. Minamoto,et al.  Expression of alphav integrin family in gastric carcinomas: increased alphavbeta6 is associated with lymph node metastasis. , 2003, Pathology, research and practice.

[23]  H. Thomas,et al.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.

[24]  G. Rice,et al.  αvβ6 Integrin-A Marker for the Malignant Potential of Epithelial Ovarian Cancer , 2002 .

[25]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[26]  R. Jordan,et al.  Tenascin and β6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas , 2002 .

[27]  G. Rice,et al.  Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer. , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  R. Jordan,et al.  Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. , 2002, Oral oncology.

[29]  R. Pytela,et al.  Role of the αvβ6 Integrin in Human Oral Squamous Cell Carcinoma Growth in Vivo and in Vitro , 2001 .

[30]  R. Pytela,et al.  Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. , 2001, Biochemical and biophysical research communications.

[31]  B. le Bail,et al.  Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. , 2000, The American journal of surgical pathology.

[32]  G. Mizejewski,et al.  Role of integrins in cancer: survey of expression patterns. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[33]  Lily T Ma,et al.  Combined hepatocellular‐cholangiocarcinoma: A clinicopathological study , 1998, Journal of gastroenterology and hepatology.

[34]  J. Lau,et al.  Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. , 1996, The American journal of pathology.

[35]  T. Kudo,et al.  Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1. , 1995, The Tohoku journal of experimental medicine.

[36]  K. Aldape,et al.  Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. , 1995, Journal of cell science.

[37]  C. Van Waes.  Cell adhesion and regulatory molecules involved in tumor formation, hemostasis, and wound healing , 1995, Head & neck.

[38]  R. Joplin.  Isolation and culture of biliary epithelial cells. , 1994, Gut.

[39]  D. Sheppard,et al.  Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  V. Desmet,et al.  Integrins as differential cell lineage markers of primary liver tumors. , 1993, The American journal of pathology.

[41]  G. Stamp,et al.  Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors. , 1992, Human pathology.

[42]  Y. Kondō,et al.  Well‐Differentiated Cholangiocarcinoma: Diagnostic Significance of Morphologic and Immunohistochemical Parameters , 1989, The American journal of surgical pathology.

[43]  S. Sell,et al.  Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. , 1989, The American journal of pathology.

[44]  T. Morohoshi,et al.  The significance of alpha‐fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours , 1989, Histopathology.

[45]  S. Thung,et al.  Blood-group-related antigen Lewis(x) and Lewis(y) in the differential diagnosis of cholangiocarcinoma and hepatocellular carcinoma. , 1989, Archives of pathology & laboratory medicine.

[46]  M. Nadji,et al.  Histologic markers in primary and metastatic tumors of the liver , 1988, Cancer.